Sleep-Disordered Breathing — MCCQE1 Clinical Presentation Guide 2026

About This Page

This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.

Key points

OSA clues: loud snoring, witnessed apnoeas/gasping, unrefreshing sleep, morning headache, daytime sleepiness, resistant hypertension, AF, obesity or large neck circumference
Safety questions are mandatory: driving, commercial driving, operating machinery, near-misses, occupational risk, and severe sleepiness
Do not diagnose OSA from symptoms alone when treatment decisions matter — confirm with polysomnography or appropriate home sleep apnoea testing
CPAP is first-line for moderate-severe symptomatic OSA; oral appliances may suit mild-moderate disease or CPAP intolerance; weight management and alcohol/sedative reduction are core
Consider obesity hypoventilation when obesity plus daytime hypercapnia, high bicarbonate, morning headaches, hypoxia, pulmonary hypertension, or right heart failure is present

Approach to the Presentation

Sleep-disordered breathing appears in MCC objectives under sleep-wake disorders and in many comorbidity stems such as hypertension, atrial fibrillation, obesity, fatigue, depression, and pre-operative risk. The clinical approach begins with a full sleep history, collateral history from a bed partner where possible, daytime function, occupational/driving safety, medications/substances, and cardiometabolic complications. The key distinction is obstructive sleep apnoea versus central sleep apnoea, sleep-related hypoventilation, insomnia, circadian disorder, restless legs, narcolepsy, depression, or medication-related sedation. In Canadian practice, access and wait-time triage matter: severe suspected OSA with comorbidity or safety-critical occupation warrants prioritised assessment.

Differential Diagnosis

diagnosis	likelihood	key features	distinguishing test
Obesity Hypoventilation Syndrome	must-not-miss	Obesity with daytime hypercapnia, hypersomnolence, morning headaches, hypoxaemia, pulmonary hypertension/right HF; often overlaps with OSA	ABG PaCO2 elevation while awake; serum bicarbonate elevated; sleep study; exclude other hypoventilation causes
Central Sleep Apnoea / Cheyne-Stokes Breathing	must-not-miss	Witnessed apnoeas without obstruction, heart failure, stroke, opioid use, high altitude; periodic crescendo-decrescendo breathing	Polysomnography differentiating central from obstructive events; echocardiography if HF suspected
Obstructive Sleep Apnoea	common	Loud snoring, witnessed apnoeas, gasping/choking, daytime sleepiness, morning headaches, nocturia, obesity, large neck, hypertension, AF	Polysomnography or validated home sleep apnoea test showing obstructive events and AHI/oxygen desaturation burden
Insomnia Disorder	common	Difficulty initiating/maintaining sleep with daytime impairment; often hyperarousal, anxiety, depression, poor sleep habits; not primarily apnoeic	Clinical sleep history/sleep diary; screen for OSA before sedatives if snoring/apnoeas present
Restless Legs Syndrome / Periodic Limb Movement Disorder	common	Urge to move legs worse at rest/evening, relieved by movement; bed partner reports kicking; associated iron deficiency, pregnancy, CKD	Clinical criteria; ferritin/iron studies; PSG if periodic limb movements uncertain
Medication/Substance-Related Sleepiness	common	Sedatives, opioids, alcohol, cannabis, antihistamines, antipsychotics, gabapentinoids; worsens snoring/OSA and impairs driving	Medication/substance review and response to reduction where safe
Depression / Anxiety	common	Fatigue, non-restorative sleep, early morning waking or hypersomnia, low mood/anhedonia, poor concentration; may coexist with OSA	Clinical screening (PHQ-9/GAD-7) while assessing sleep breathing symptoms
Shift Work / Circadian Rhythm Disorder	common	Sleepiness aligned with work schedule/time-zone mismatch; normal breathing history; irregular sleep timing	Sleep diary/actigraphy if needed; occupational history
Narcolepsy	less common	Excessive daytime sleepiness with cataplexy, sleep paralysis, hypnagogic hallucinations, sleep attacks; usually younger onset	Polysomnography followed by multiple sleep latency test after adequate sleep documentation
Hypothyroidism	less common	Fatigue, weight gain, cold intolerance, constipation, bradycardia, macroglossia; can worsen OSA	TSH and free T4

Red Flags & Key History

Symptoms

Falling asleep while driving, near-misses, commercial driving, operating machinery — urgent safety counselling

Witnessed apnoeas, choking/gasping, loud habitual snoring

Severe daytime sleepiness with occupational risk or comorbid cardiovascular disease

Morning headaches, hypoxaemia, oedema, pulmonary hypertension — consider obesity hypoventilation

Heart failure, stroke, chronic opioid use — central sleep apnoea risk

Cataplexy, sleep paralysis, hallucinations — narcolepsy rather than simple OSA

Signs

BMI/waist circumference/neck circumference elevated

Crowded oropharynx, large tonsils, retrognathia, nasal obstruction

Hypertension, especially resistant hypertension

Signs of pulmonary hypertension/right heart failure: loud P2, elevated JVP, oedema

Resting hypoxaemia or hypercapnia signs — not uncomplicated OSA

Approach to Investigation

First-line

Sleep history + collateral historySnoring, apnoeas, choking, sleep position, nocturia, morning headache, daytime sleepiness, driving/work safety, alcohol/sedatives/opioids, sleep duration, shift work

Screening toolsSTOP-Bang, Epworth Sleepiness Scale, Berlin questionnaire can risk-stratify but do not replace diagnostic testing

Cardiometabolic assessmentBP, BMI/waist, diabetes/lipid risk, AF/HF history. OSA often appears through resistant hypertension or AF

Medication/substance reviewAlcohol, opioids, benzodiazepines, sedating antidepressants/antipsychotics, antihistamines, cannabis, gabapentinoids

Second-line

PolysomnographyGold standard, especially for complex comorbidity, suspected central sleep apnoea, hypoventilation, neuromuscular disease, severe insomnia, or inconclusive home testing

Home sleep apnoea testingAppropriate for selected adults with high pre-test probability of uncomplicated moderate-severe OSA, depending on provincial access and local criteria

Serum bicarbonate / ABGScreen for chronic hypoventilation if obesity hypoventilation suspected. Elevated bicarbonate suggests chronic CO2 retention; ABG confirms daytime hypercapnia

TSH, ferritin, CBC as indicatedIf fatigue differential includes hypothyroidism, restless legs/iron deficiency, anaemia, or other systemic causes

Specialist

Sleep medicine referralSevere symptoms, safety-critical occupation, cardiopulmonary comorbidity, suspected central apnoea, hypoventilation, paediatric OSA, CPAP intolerance, or uncertain diagnosis

ENT/dentistry assessmentTonsillar hypertrophy, nasal obstruction, craniofacial risk, consideration of oral appliance or surgical options

Management Principles

Canadian Thoracic Society Sleep-Disordered Breathing Guidance + Canadian Thoracic Society/Canadian Sleep Society portable monitoring position

Safety and triage

Counsel patients with excessive sleepiness not to drive or perform safety-sensitive work until adequately assessed/treated, following provincial regulations and professional duties
Prioritise urgent assessment for suspected severe OSA with comorbid cardiovascular disease, hypoventilation, or safety-critical occupation
Review sedatives, alcohol, cannabis, and opioids that worsen apnoea and sleepiness

OSA treatment

CPAP/APAP is first-line for moderate-severe symptomatic OSA and for OSA with relevant comorbidities
Weight management, regular exercise, positional therapy where positional OSA, reduced evening alcohol/sedatives, nasal obstruction treatment
Mandibular advancement oral appliance for selected mild-moderate OSA or CPAP-intolerant patients with appropriate dentition
Treat comorbid hypertension, AF, diabetes risk, depression, and cardiovascular disease in parallel

Hypoventilation and central apnoea

Obesity hypoventilation often requires positive airway pressure and specialist-led assessment; CPAP may be sufficient if OSA-predominant, bilevel ventilation if persistent hypercapnia/hypoventilation
Central sleep apnoea: optimise underlying HF, reduce opioids where safe, and involve sleep/cardiology specialists for device decisions

Follow-up

Assess adherence, mask fit, residual symptoms, residual AHI/leak from device data, blood pressure, sleepiness, and driving/work safety
Address barriers: nasal symptoms, claustrophobia, pressure intolerance, cost/access, and health literacy

Complications & Pitfalls

Driving safety omission: Excessive sleepiness with driving risk is an immediate counselling and documentation issue.
Symptoms-only diagnosis: Snoring is common; confirm OSA when treatment, occupational advice, or comorbidity management depends on it.
Missing obesity hypoventilation: Daytime hypercapnia, high bicarbonate, hypoxaemia, oedema, or pulmonary hypertension is beyond uncomplicated OSA.
Sedative prescribing: Benzodiazepines, opioids, alcohol, and other sedatives can worsen sleep-disordered breathing and driving risk.
CPAP without support: Mask fit, education, humidification, and follow-up often determine adherence more than the prescription itself.

MCCQE1 Exam Tips

1Classic OSA stem: obese patient, loud snoring, witnessed apnoeas, daytime sleepiness, hypertension. Next step: sleep study/home sleep testing depending on context
2Do not prescribe sedatives for insomnia before screening for OSA when snoring/apnoeas/daytime sleepiness are present
3Commercial driver with sleepiness = immediate safety counselling and expedited assessment
4OSA and resistant hypertension/AF are linked; treating OSA is part of cardiovascular risk management
5Obesity + daytime hypercapnia/high bicarbonate = obesity hypoventilation, not simple OSA
6CPAP is first-line for moderate-severe symptomatic OSA; oral appliance is a reasonable alternative for selected mild-moderate or CPAP-intolerant patients
7CanMEDS communicator: involve the bed partner/collateral history where possible — witnessed apnoeas are often not known to the patient

Put your reading into practice

Topic-specific question practice is not linked for this article yet.

Choose MCCQE Part I questions from the existing bank. General exam practice covers your selected topics; it is not filtered to this article. Your usual question-bank access applies.

Choose MCCQE Part I practice

After your session, return to this section to revisit the reading and choose your next review.